Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the recipient of a significant drop in short interest in May. As of May 29th, there was short interest totaling 28,220 shares, a drop of 34.7% from the May 14th total of 43,223 shares. Based on an average daily volume of 40,742 shares, the days-to-cover ratio is currently 0.7 days. Approximately 1.2% of the company’s shares are sold short.
Innovator IBD 50 ETF Price Performance
Shares of Innovator IBD 50 ETF stock traded down $0.49 during midday trading on Tuesday, reaching $42.01. The company had a trading volume of 28,249 shares, compared to its average volume of 73,371. The stock has a fifty day moving average price of $38.93 and a 200 day moving average price of $37.39. The firm has a market cap of $96.62 million, a PE ratio of 30.34 and a beta of 1.47. Innovator IBD 50 ETF has a fifty-two week low of $30.02 and a fifty-two week high of $42.72.
Hedge Funds Weigh In On Innovator IBD 50 ETF
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. AlphaCore Capital LLC acquired a new stake in shares of Innovator IBD 50 ETF during the fourth quarter worth $32,000. International Assets Investment Management LLC acquired a new stake in shares of Innovator IBD 50 ETF during the fourth quarter worth $35,000. Simplex Trading LLC acquired a new stake in shares of Innovator IBD 50 ETF during the fourth quarter worth $41,000. Advisory Services Network LLC acquired a new stake in shares of Innovator IBD 50 ETF during the third quarter worth $43,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Innovator IBD 50 ETF during the fourth quarter worth $72,000.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Recommended Stories
- Five stocks we like better than Innovator IBD 50 ETF
- AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
- 3 Dividend Kings With Income, Stability, and a Possible Catalyst
- Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media
- Goldman’s S&P 500 Target Looks More Reachable After the Latest Rally
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
